
Pubmed-entry ::= {
  pmid 29943557,
  medent {
    em std {
      year 2018,
      month 6,
      day 27,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Clinical Implication of Sarcopenia in Patients with Inflammatory
 Bowel Disease."
      },
      authors {
        names std {
          {
            name ml "Kim SE",
            affil str "Department of Internal Medicine, Ewha Womans University
 College of Medicine, Seoul, Korea."
          }
        }
      },
      from journal {
        title {
          iso-jta "Korean J Gastroenterol",
          ml-jta "Korean J Gastroenterol",
          issn "2233-6869",
          name "The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe
 chi"
        },
        imp {
          date std {
            year 2018,
            month 6,
            day 25
          },
          volume "71",
          issue "6",
          pages "308-314",
          language "kor",
          pubstatus ppublish,
          history {
            {
              pubstatus other,
              date std {
                year 2018,
                month 6,
                day 27,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 6,
                day 27,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2019,
                month 2,
                day 1,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29943557,
        pii "10.4166kjg.2018.71.6.308",
        doi "10.4166/kjg.2018.71.6.308",
        other {
          db "ELocationID doi",
          tag str "10.4166/kjg.2018.71.6.308"
        }
      }
    },
    abstract "Recent studies have shown that inflammatory bowel disease (IBD)
 patients are affected by altered body composition, especially low muscle mass
 or sarcopenia. Detection of sarcopenia is important, as it can independently
 predict osteopenia, sarcopenic obesity, and poor disease outcomes during IBD
 progress. The challenges are needed to identify diagnostic and managing
 strategies for sarcopenia in IBD to improve disease outcomes and increase the
 quality of life in patients with IBD.",
    mesh {
      {
        term "Body Composition"
      },
      {
        term "Body Mass Index"
      },
      {
        term "Bone and Bones",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Cytokines",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Inflammatory Bowel Diseases",
        qual {
          {
            subh "complications"
          },
          {
            subh "metabolism"
          },
          {
            mp TRUE,
            subh "pathology"
          }
        }
      },
      {
        term "Muscle, Skeletal",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Obesity",
        qual {
          {
            subh "etiology"
          }
        }
      },
      {
        term "Sarcopenia",
        qual {
          {
            subh "complications"
          },
          {
            mp TRUE,
            subh "pathology"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Cytokines"
      }
    },
    pmid 29943557,
    pub-type {
      "Journal Article",
      "Review"
    },
    status medline
  }
}


